| Brain charts for the human lifespan RAI Bethlehem, J Seidlitz, SR White, JW Vogel, KM Anderson, ... Nature 604 (7906), 525-533, 2022 | 1077 | 2022 |
| Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline R Ossenkoppele, A Pichet Binette, C Groot, R Smith, O Strandberg, ... Nature medicine 28 (11), 2381-2387, 2022 | 246 | 2022 |
| Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring NJ Ashton, S Janelidze, N Mattsson-Carlgren, AP Binette, O Strandberg, ... Nature medicine 28 (12), 2555-2562, 2022 | 241 | 2022 |
| Neuronal driven pre-plaque inflammation in a transgenic rat model of Alzheimer's disease CE Hanzel, A Pichet-Binette, LSB Pimentel, MF Iulita, S Allard, ... Neurobiology of aging 35 (10), 2249-2262, 2014 | 182 | 2014 |
| Prevalence estimates of amyloid abnormality across the Alzheimer disease clinical spectrum WJ Jansen, O Janssen, BM Tijms, SJB Vos, R Ossenkoppele, PJ Visser, ... JAMA neurology 79 (3), 228-243, 2022 | 164 | 2022 |
| Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance A Pichet Binette, S Janelidze, N Cullen, JL Dage, RJ Bateman, ... Alzheimer's & Dementia 19 (4), 1403-1414, 2023 | 117 | 2023 |
| Biomarker-based prediction of longitudinal tau positron emission tomography in Alzheimer disease A Leuzy, R Smith, NC Cullen, O Strandberg, JW Vogel, AP Binette, ... JAMA neurology 79 (2), 149-158, 2022 | 103 | 2022 |
| Characterization of Alzheimer disease biomarker discrepancies using cerebrospinal fluid phosphorylated tau and AV1451 positron emission tomography PF Meyer, AP Binette, J Gonneaud, JCS Breitner, S Villeneuve, ... JAMA neurology 77 (4), 508-516, 2020 | 102 | 2020 |
| CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer’s disease K Horie, G Salvadó, NR Barthélemy, S Janelidze, Y Li, Y He, B Saef, ... Nature medicine 29 (8), 1954-1963, 2023 | 101 | 2023 |
| Repetitive negative thinking is associated with amyloid, tau, and cognitive decline NL Marchant, LR Lovland, R Jones, A Pichet Binette, J Gonneaud, ... Alzheimer's & Dementia 16 (7), 1054-1064, 2020 | 93 | 2020 |
| Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer’s disease J Tremblay-Mercier, C Madjar, S Das, AP Binette, SOM Dyke, P Étienne, ... NeuroImage: Clinical 31, 102733, 2021 | 89 | 2021 |
| Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease A Pichet Binette, N Franzmeier, N Spotorno, M Ewers, M Brendel, D Biel, ... Nature communications 13 (1), 6635, 2022 | 78 | 2022 |
| Subjective cognitive decline is associated with altered default mode network connectivity in individuals with a family history of Alzheimer’s disease SCJ Verfaillie, AP Binette, E Vachon-Presseau, S Tabrizi, M Savard, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3 (5), 463-472, 2018 | 76 | 2018 |
| Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease J Gonneaud, AT Baria, A Pichet Binette, BA Gordon, JP Chhatwal, ... Nature communications 12 (1), 5346, 2021 | 75 | 2021 |
| Association of elevated amyloid and tau positron emission tomography signal with near-term development of Alzheimer disease symptoms in older adults without cognitive impairment C Strikwerda-Brown, DA Hobbs, J Gonneaud, F St-Onge, AP Binette, ... JAMA neurology 79 (10), 975-985, 2022 | 73 | 2022 |
| Plasma p‐tau231, p‐tau181, PET biomarkers, and cognitive change in older adults PF Meyer, NJ Ashton, TK Karikari, C Strikwerda‐Brown, T Köbe, ... Annals of neurology 91 (4), 548-560, 2022 | 67 | 2022 |
| Amyloid and tau pathology associations with personality traits, neuropsychiatric symptoms, and cognitive lifestyle in the preclinical phases of sporadic and autosomal dominant … AP Binette, É Vachon-Presseau, J Morris, R Bateman, T Benzinger, ... Biological psychiatry 89 (8), 776-785, 2021 | 60 | 2021 |
| Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease JW Vogel, E Vachon-Presseau, A Pichet Binette, A Tam, P Orban, ... Brain 141 (6), 1871-1883, 2018 | 60 | 2018 |
| Divergent regional patterns of cerebral hypoperfusion and gray matter atrophy in mild cognitive impairment patients M Wirth, A Pichet Binette, P Brunecker, T Köbe, AV Witte, A Flöel Journal of Cerebral Blood Flow & Metabolism 37 (3), 814-824, 2017 | 60 | 2017 |
| Morphometric network differences in ageing versus Alzheimer’s disease dementia A Pichet Binette, J Gonneaud, JW Vogel, R La Joie, P Rosa-Neto, ... Brain 143 (2), 635-649, 2020 | 58 | 2020 |